Medicus Pharma Ltd. — Form SCHEDULE 13D
Filed September 14, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 32/100
What the filing says
Dr. Raza Bokhari and RBx Capital, LP filed a joint Schedule 13D on September 14, 2026, indicating a significant shareholding position in Medicus Pharma Ltd. The filing establishes a joint filing arrangement between Bokhari (as managing partner of RBx Capital) and the fund itself. Specific share count, percentage ownership, acquisition dates, and price details are not disclosed in this exhibit.
Why this rating
Filing itself is procedural; specifics (ownership %, shares, intent) absent. Context needed to assess materiality to $28.3M company.
See more from September 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.